ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy

Epilepsia

Volumn 46, Issue 1, 2005, Pages 110-117

  Gambardella, Antonio ^a,b   Aguglia, Umberto ^c   Chifari, Rosanna ^d   Labate, Angelo ^a,b   Manna, Ida ^b   Serra, Paolo ^b   Romeo, Nelide ^b   Sibilia, Grazia ^a   LePiane, Emilio ^c   La Russa, Antonella ^b   Ventura, Patrizia ^b   Cittadella, Rita ^b   Sasanelli, Francesco ^d   Colosimo, Eleonora ^a   Leggio, Ugo ^a   Zappia, Mario ^a,b   Quattrone, Aldo ^a,b,e  

^a School of Medicine   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c Hospital of Reggio Calabria   (Italy)

^d Hospital of Melegnano   (Italy)

^e UNIVERSITY OF CHIETI   (Italy)

Author keywords

ApoE; Genetic predisposition; Temporal lobe epilepsy; Verbal memory

Indexed keywords

APOLIPOPROTEIN E;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; EDUCATION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; LEARNING; LEARNING DISORDER; MALE; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PRIORITY JOURNAL; TEMPORAL LOBE EPILEPSY;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; COGNITION DISORDERS; EDUCATIONAL STATUS; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; VERBAL LEARNING;

EID: 19944433841     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0013-9580.2005.15804.x     Document Type: Article

References (57)

1. Helmstaedter C, Kurthen M. Memory and epilepsy, characteristics, course and influence of drugs and surgery. Curr Opin Neurol 2001;14:211-6.
2. Wilson BA, Clare L. Rehabilitation of memory disorders. In: Greenwood R, Barnes M, McMillan TM, et al., eds. Handbook of neurological rehabilitation. 2nd ed. Hove, UK: Psychological Press, 2003:377-88.
3. Thompson PJ. Epilepsy and memory. In: Cull C, Goldstein L, eds. Clinical psychologists handbook of epilepsy. London: Routledge, 1997:35-53.
4. Meador K, Loring D. Cognitive effects of antiepileptic drugs. In: Devinsky O, Theodore W, eds. Epilepsy and behavior. New York: Wiley-Liss, 1991:151-70.
5. Helmstaedter C, Kurthen M, Lux S, et al. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol 2003;54:425-32.
6. Rausch R, Kraemer S, Pietras CJ, et al. Early and late cognitive changes following temporal lobe surgery. Neurology 2003;60:952-9.
7. Duncan JS. The cognitive consequences of epilepsy. Ann Neurol 2003;54:421-2.
8. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:9649-53.
9. Mackenzie IR, Miller LA. Senile plaques in temporal lobe epilepsy. Acta Neuropathol (Berl) 1994;87:504-10.
10. Sheng JG, Boop FA, Mrak RE, et al. Increased neuronal beta-amyloid precursor protein expression in human temporal lobe epilepsy: association with interleukin-1 alpha immunoreactivity. J Neurochem 1994;63:1872-9.
11. Gouras GK, Relkin NR, Sweeney D, et al. Increased apolipoprotein E epsilon 4 in epilepsy with senile plaques. Ann Neurol 1997;41:402-4.
12. Poirier J. Apoliprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci 1994;17:525-30.
13. Aguglia U, Gambardella A, LePiane E, et al. Mild non-lesional temporal lobe epilepsy: a common, unrecognized disorder with onset in adulthood. Can J Neurol Sci 1998;25:282-6.
14. Gambardella A, Aguglia U, Cittadella R, et al. Apolipoprotein E polymorphisms and the risk of nonlesional temporal lobe epilepsy. Epilepsia 1999;40:1804-7.
15. Gambardella A, Manna I, Labate A, et al. GABA(B) receptor 1 polymorphism (G1465A) is associated with temporal lobe epilepsy. Neurology 2003;60:560-3.
16. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99.
17. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.
18. Rey A. Mémorisation d'une série de 15 mots en 5 répétitions. In: Rey A, ed. L'examen clinique en psychologie. Paris: Presses Universitaire de France, 1958.
19. Caltagirone C, Gainotti G, Masullo C, et al. Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychol Scand 1979;60:50-6.
20. Corsi P. Interhemispheric differences in the localization of psychological processes in man. Thesis. Montreal: University of Montreal, 1972.
21. Borkowsky JG, Benton AL, Spreen O. Word fluency and brain damage. Neuropsychologia 1967;5:135-40.
22. Gainotti G, Caltagirone C, Miceli G. Sui rapporti fra alcune prove di intelligenza verbale e lesioni focali monoemisferiche. Acta Neurol 1976;31:370-81.
23. Raven JC. Progressive matrices: sets A, AbB. In: Lewis HK, ed. Board and book forms. London: 1947.
24. Heaton RK. Wisconsin Card Sorting Test manual. In: Psychological assessment resources. Odessa, FL: 1981.
25. De Renzi E, Vignolo LA. The Token test: a sensitive test to detect receptive disturbances in aphasia. Brain 1962;85:665-78.
26. Stroop JR. Studies of interference in serial verbal reaction. J Exp Psychol 1935;18:643-62.
27. Spinnler H, Tognoni G. Standardizzazione e taratura italiana dei test neuropsicologici. Italy J Neurol Sci 1987;6:8-20.
28. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. Eur Neurol 1996;36:378-84.
29. Grigoletto F, Zappala G, Anderson DW, et al. Norms for the Mini-Mental State Examination in a healthy population. Neurology 1999;53:315-20.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;5:56-62.
31. Wenham PR, Price WH, Blundel G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
32. Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am J Hum Genet 2002;71:304-11.
33. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992;48:361-72.
34. Muros M, Rodigruez-Ferre C. Apolipoprotein E polymorphism influence on lipids, apoliproteins and Lp(a) in a Spanish population underexpressing ApoE ε4. Atherosclerosis 1996;121:13-21.
35. Mattson MP, Cheng B, Davis D, et al. Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitoxicity. J Neurosci 1992;12:376-89.
36. Meyer MR, Tschanz JT, Norton MC, et al. ApoE genotype predicts when - not whether - one is predisposed to develop Alzheimer's disease. Nat Genet 1998;19:321-2.
37. Teasdale GM, Nicoll JA, Murray G, et al. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997;350:1069-71.
38. Caselli RJ, Reiman EM, Osborne D, et al. Longitudinal changes in cognition and behavior in asymptomatic carriers of the ApoE ε4 allele. Neurology 2004;62:1990-5.
39. Kalviainen R, Partanen K, Aikia M, et al. Apolipoprotein E polymorphism in relation to hippocampal cell damage and memory impairment in newly diagnosed partial epilepsy. Neurology 1998;50:A141-2.
40. Briellmann RS, Torn-Broers Y, Busuttil BE, et al. ApoE epsilon4 genotype is associated with an earlier onset of chronic temporal lobe epilepsy. Neurology 2000;55:435-7.
41. Bengzon J, Kokaia Z, Elmer E, et al. Apoptosis and proliferation of dentate gyrus neurons after single and intermittent limbic seizures. Proc Natl Acad Sci U S A 1997;94:10432-7.
42. Chang YC, Huang AM, Kuo YM, et al. Febrile seizures impair memory and cAMP response-element binding protein activation. Ann Neurol 2003;54:706-18.
43. Briellmann RS, Berkovic SF, Syngeniotis A, et al. Seizure-associated hippocampal volume loss: a longitudinal magnetic resonance study of temporal lobe epilepsy. Ann Neurol 2002 Dec; 52(6):861; author reply 862.
44. Liu RS, Lemieux L, Bell GS, et al. Progressive neocortical damage in epilepsy. Ann Neurol 2003;53:312-24.
45. O'Dougherty M, Wright FS, Cox S, et al. Carbamazepine plasma concentration: relationship to cognitive impairment. Arch Neurol 1987;44:863-7.
46. Meador KJ. Cognitive outcomes and predictive factors in epilepsy. Neurology 2002;58(suppl 5):S21-6.
47. Currie S, Heathfield KW, Henson RA, et al. Clinical course and prognosis of temporal lobe epilepsy: a survey of 666 patients. Brain 1971;94:173-90.
48. Hauser WA, The natural history of temporal lobe epilepsy. In: Lüders HO, ed. Epilepsy surgery. New York: Raven Press, 1992:133-41.
49. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998;352:1007-11.
50. Berkovic S, McIntosh A, Howell RA, et al. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann Neurol 1996;40:227-35.
51. Vadlamudi L, Scheffer IE, Berkovic SF. Genetics of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003;74:1359-61.
52. Koutroumanidis M, Hennessy MJ, Seed PT, et al. Significance of interictal bilateral temporal hypometabolism in temporal lobe epilepsy. Neurology 2000;54:1811-21.
53. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20.
54. Kanemoto K, Kawasaki J, Miyamoto T, et al. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000;47:571-4.
55. Stogmann E, Zimprich A, Baumgartner C, et al. A functional polymorphism in the prodynorphin gene promoter is associated with temporal lobe epilepsy. Ann Neurol 2002;51:260-3.
56. Walz R, Castro RM, Velasco TR, et al. Surgical outcome in mesial temporal sclerosis correlates with prion protein gene variant. Neurology 2003;61:1204-10.
57. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002;30:149-50.